title: Continuous therapy with sunitinib in patients with metastatic renal cell carcinoma.
authors.forename: Christoph
authors.initials: C
authors.lastname: Kahl
authors.forename: Inken
authors.initials: I
authors.lastname: Hilgendorf
authors.forename: Mathias
authors.initials: M
authors.lastname: Freund
authors.forename: Jochen
authors.initials: J
authors.lastname: Casper
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000008:administration & dosage*; D000077210:Sunitinib; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib